These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27043121)

  • 1. Separate and Combined Effects of Naltrexone and Extended-Release Alprazolam on the Reinforcing, Subject-Rated, and Cardiovascular Effects of Methamphetamine.
    Marks KR; Lile JA; Stoops WW; Glaser PE; Hays LR; Rush CR
    J Clin Psychopharmacol; 2016 Jun; 36(3):213-21. PubMed ID: 27043121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological and subjective effects of acute intranasal methamphetamine during extended-release alprazolam maintenance.
    Lile JA; Stoops WW; Glaser PE; Hays LR; Rush CR
    Drug Alcohol Depend; 2011 Dec; 119(3):187-93. PubMed ID: 21737214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Separate and combined impact of acute naltrexone and alprazolam on subjective and physiological effects of oral d-amphetamine in stimulant users.
    Marks KR; Lile JA; Stoops WW; Rush CR
    Psychopharmacology (Berl); 2014 Jul; 231(14):2741-50. PubMed ID: 24464531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naltrexone and bupropion, alone or combined, do not alter the reinforcing effects of intranasal methamphetamine.
    Stoops WW; Pike E; Hays LR; Glaser PE; Rush CR
    Pharmacol Biochem Behav; 2015 Feb; 129():45-50. PubMed ID: 25459104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study.
    Ray LA; Bujarski S; Courtney KE; Moallem NR; Lunny K; Roche D; Leventhal AM; Shoptaw S; Heinzerling K; London ED; Miotto K
    Neuropsychopharmacology; 2015 Sep; 40(10):2347-56. PubMed ID: 25801501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methamphetamine self-administration in humans during D-amphetamine maintenance.
    Pike E; Stoops WW; Hays LR; Glaser PE; Rush CR
    J Clin Psychopharmacol; 2014 Dec; 34(6):675-81. PubMed ID: 25154010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of aripiprazole pretreatment on the reinforcing effects of methamphetamine in humans.
    Stoops WW; Bennett JA; Lile JA; Sevak RJ; Rush CR
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():111-7. PubMed ID: 23994622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buspirone maintenance does not alter the reinforcing, subjective, and cardiovascular effects of intranasal methamphetamine.
    Reynolds AR; Strickland JC; Stoops WW; Lile JA; Rush CR
    Drug Alcohol Depend; 2017 Dec; 181():25-29. PubMed ID: 29028556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance.
    Rush CR; Stoops WW; Lile JA; Glaser PE; Hays LR
    Psychopharmacology (Berl); 2011 Apr; 214(3):665-74. PubMed ID: 21072503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reinforcing, subject-rated, performance, and cardiovascular effects of d-amphetamine: influence of sensation-seeking status.
    Stoops WW; Lile JA; Robbins CG; Martin CA; Rush CR; Kelly TH
    Addict Behav; 2007 Jun; 32(6):1177-88. PubMed ID: 17011712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder.
    Mooney LJ; Hillhouse MP; Thomas C; Ang A; Sharma G; Terry G; Chang L; Walker R; Trivedi M; Croteau D; Sparenborg S; Ling W
    J Addict Med; 2016; 10(4):236-43. PubMed ID: 27379819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial.
    Krupitsky E; Nunes EV; Ling W; Illeperuma A; Gastfriend DR; Silverman BL
    Lancet; 2011 Apr; 377(9776):1506-13. PubMed ID: 21529928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute physiological and behavioral effects of intranasal methamphetamine in humans.
    Hart CL; Gunderson EW; Perez A; Kirkpatrick MG; Thurmond A; Comer SD; Foltin RW
    Neuropsychopharmacology; 2008 Jul; 33(8):1847-55. PubMed ID: 17851535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended-release naltrexone for methamphetamine dependence among men who have sex with men: a randomized placebo-controlled trial.
    Coffin PO; Santos GM; Hern J; Vittinghoff E; Santos D; Matheson T; Colfax G; Batki SL
    Addiction; 2018 Feb; 113(2):268-278. PubMed ID: 28734107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxazepam does not modulate the behavioral effects of d-amphetamine in humans.
    Lile JA; Stoops WW; Wagner FP; Glaser PE; Rush CR
    Pharmacol Biochem Behav; 2005 Oct; 82(2):270-9. PubMed ID: 16182353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiological and subjective effects of acute intranasal methamphetamine during atomoxetine maintenance.
    Rush CR; Stoops WW; Lile JA; Glaser PE; Hays LR
    Pharmacol Biochem Behav; 2011 Nov; 100(1):40-7. PubMed ID: 21802442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acute topiramate dosing on methamphetamine-induced subjective mood.
    Johnson BA; Roache JD; Ait-Daoud N; Wells LT; Wallace CL; Dawes MA; Liu L; Wang XQ
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):85-98. PubMed ID: 16448579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminative-stimulus, subject-rated, and physiological effects of methamphetamine in humans pretreated with aripiprazole.
    Sevak RJ; Vansickel AR; Stoops WW; Glaser PE; Hays LR; Rush CR
    J Clin Psychopharmacol; 2011 Aug; 31(4):470-80. PubMed ID: 21694622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bupropion and Naltrexone in Methamphetamine Use Disorder.
    Trivedi MH; Walker R; Ling W; Dela Cruz A; Sharma G; Carmody T; Ghitza UE; Wahle A; Kim M; Shores-Wilson K; Sparenborg S; Coffin P; Schmitz J; Wiest K; Bart G; Sonne SC; Wakhlu S; Rush AJ; Nunes EV; Shoptaw S
    N Engl J Med; 2021 Jan; 384(2):140-153. PubMed ID: 33497547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alprazolam absorption kinetics affects abuse liability.
    Mumford GK; Evans SM; Fleishaker JC; Griffiths RR
    Clin Pharmacol Ther; 1995 Mar; 57(3):356-65. PubMed ID: 7697954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.